A pediatric surgeon's dilemma: does cholecystectomy improve symptoms of biliary dyskinesia?

Heather L Liebe1, Ryan Phillips2, Meghan Handley2

  • 1Ochsner Clinic Foundation, 1514 Jefferson Hwy, New Orleans, LA, 70121, USA. heather.liebe@gmail.com.

Insights

Cholecystectomy offers durable symptom relief for pediatric biliary dyskinesia (BD) patients with post-prandial pain. However, those without this specific symptom experience less improvement, highlighting the need for alternative diagnoses before surgery.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Outcomes
  • Gallbladder Pathophysiology

Background:

  • Biliary dyskinesia (BD) is a recognized gallbladder condition in adults, with increasing cholecystectomy rates.
  • Pediatric patients with vague abdominal pain are often evaluated for BD, but predictors of surgical success remain unclear.
  • Laparoscopic cholecystectomy is a common treatment, yet its effectiveness in resolving symptoms in children requires further investigation.

Purpose of the Study:

  • To determine if laparoscopic cholecystectomy leads to sustained symptom relief in pediatric patients diagnosed with BD.
  • To assess the impact of cholecystectomy on the frequency of gastrointestinal (GI)-related medical visits post-surgery.
  • To identify patient subgroups most likely to benefit from cholecystectomy for BD.

Main Methods:

  • A multi-institution retrospective review of pediatric patients (<18 years) who underwent laparoscopic cholecystectomy for BD (January 2013 - April 2018).
  • Assessment of preoperative GI symptoms and clinical visits related to GI complaints.
  • Postoperative follow-up at 6 months and 2 years to quantify symptom resolution and compare GI-related medical visit rates to preoperative values.

Main Results:

  • 45 pediatric patients (82% female, average age 14) were included; 56% were overweight or obese.
  • Postoperatively, symptom resolution varied: abdominal pain (58% at 6 months, 38% at 2 years), nausea (59% at 6 months, 43% at 2 years), and post-prandial pain (100% at 6 months, 91% at 2 years).
  • Total GI-related clinical visits decreased significantly from a preoperative mean of 2.6 to 1.0 within 6 months and 0.71 by 2 years post-surgery.

Conclusions:

  • Cholecystectomy demonstrated durable symptom resolution, particularly for pediatric BD patients presenting with post-prandial pain.
  • Patients without post-prandial pain showed lower symptom resolution rates, suggesting the need to explore alternative diagnoses preoperatively.
  • While cholecystectomy reduced GI-related visits for all BD patients, no specific preoperative factor predicted this reduction.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
53
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
1.4K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
428
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
570
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
594